
Metovav 23.75mg Tablet ER
Marketer
Inavars Biologicals Inc
Salt Composition
Metoprolol Succinate (23.75mg)
Overview Metovav 23.75mg Tablet ER
CardioBeta 23.75mg Extended-Release tablets are classified as beta-adrenergic blockers. This medication treats hypertension (high blood pressure), angina pectoris (chest pain due to heart issues), and cardiac arrhythmias (irregular heartbeats). It's also used to prevent migraine headaches, future myocardial infarctions (heart attacks), and cerebrovascular accidents (strokes). CardioBeta 23.75mg ER may be administered independently or in conjunction with other therapies. Dosage and frequency are determined by the treated condition and its severity. It can be taken with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefits may take weeks to manifest, and continuous use might be necessary. Discontinuing treatment, even with symptom improvement, can exacerbate the underlying condition. Common side effects, often mild and transient, include fatigue, cephalalgia (headache), depressive symptoms, diarrhea, skin rash, bradycardia (slow heart rate), dizziness, and nausea. Less frequent side effects include dyspnea (shortness of breath) and hypotension (low blood pressure). Gradual dose escalation minimizes adverse reactions. Report persistent or troublesome side effects to your physician. Prior to commencing treatment, inform your doctor of any hepatic (liver) impairment. This medication may be unsuitable for individuals with bradycardia, significant circulatory disorders, severe congestive heart failure, or hypotension. Pregnant or lactating women should seek medical advice. Always consult your doctor to assess suitability. Regular blood pressure monitoring ensures therapeutic effectiveness. Alcohol consumption should be limited due to potential exacerbation of side effects.
Uses of Metovav 23.75mg Tablet ER
Managing angina pectoris (chest pain due to heart issues) | Correcting cardiac arrhythmias | Reducing the risk of myocardial infarction | Controlling hypertension (high blood pressure) | Preventing migraine episodes
Major Benefits of Metovav 23.75mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Metovav 23.75mg Extended-Release Tablets. Swallow the tablet whole; do not chew, crush, or divide it. These tablets can be taken with or without food, but consistency in timing is recommended. Minimize consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and fatty meats while taking Metovav 23.75mg ER Tablets.
Common Side effects of Metovav 23.75mg Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metovav 23.75mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Metovav 23.75mg Extended-Release Tablets. Swallow the tablet whole; do not chew, crush, or break it. These tablets can be taken with or without food, but consistent timing is recommended. Minimize consumption of high-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and fatty meats, while taking Metovav 23.75mg ER tablets.
How Metovav 23.75mg Tablet ER works:
Extended-release Metovav 23.75mg tablets are a cardioselective beta-blocker designed to prolong the duration of therapeutic effects. The medication reduces heart rate and improves the heart's pumping efficiency, thereby enhancing circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metovav 23.75mg Extended-Release Tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metovav 23.75mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metovav 23.75mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Metovav 23.75mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneySAFE IF PRESCRIBED
Extended-release Metovav 23.75 mg tablets are considered safe for individuals with impaired kidney function. No alteration of the Metovav 23.75 mg extended-release tablet dosage is necessary.
LiverCAUTION
Extended-release Metovav 23.75mg tablets require careful administration for individuals with hepatic impairment. Dosage modification of Metovav 23.75mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Metovav 23.75mg Tablet ER :
Should you forget a Metovav 23.75mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metovav 23.75mg Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Alcohols and Phenols |
| Developing Habits | No. |
| Type of Therapy | HEART |
